Cost-effectiveness of maternal pertussis immunization: Implications of a dynamic transmission model for low- and middle-income countries.

CONCLUSION: A dynamic model, which captures the herd immunity benefits of pertussis vaccination, shows that, in low- and middle-income countries, maternal aP immunization is cost-effective when infant vaccination coverage is moderate, even cost-saving when it is low, but not cost-effective when coverage levels pass 90-95%. PMID: 33303182 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33303182?dopt=Abstract

Source: Vaccine - December 13, 2020 Category: Allergy & Immunology Authors: Kim SY, Min KD, Jung SM, Russell LB, Toscano C, Minamisava R, Andrade ALS, Sanderson C, Sinha A Tags: Vaccine Source Type: research